Clinical Trial Update: Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and feasibility of combining estramustine, docetaxel, and carboplatin in men with prostate cancer that has not responded t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Estramustine (estramustine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED